data&donuts
  • Data & Donuts (thinky thoughts)
  • COLLABORATor
  • Data talks, people mumble
  • Cancer: The Brand
  • Time to make the donuts...
  • donuts (quick nibbles)
  • Tools for writers and soon-to-be writers
  • datamonger.health
  • The "How" of Data Fluency

CANCER: THE BRAND

"Somewhere, something incredible is waiting to be known." Dr. Carl Sagan

5/19/2017

 
Picture
What a fantastic time to be in the world of scientific discovery. I have been at the bench, in the halls of academia (as a student and medical writer), worked in industry, employed as a medical education executive, and most recently, I work as a datapreneur. What is that? I like to describe datapreneur as a journalist taking cues only from data.

Discovery in the sciences is dynamic. Regardless of your pedigree or educational attainment, if you aren't in lockstep with advances in your chosen discipline, you are obsolete. There is texture in experience. And insights to gain from tireless scientists hoping to advance if not a cure perhaps a better quality of life during advanced and chronic cancers.
I need time to review my recent experiences at several recent conferences. The topics are particularly appropriate to this forum so follow along. Not everyone can jet off to conferences  listening to leading minds debate checkpoint inhibition, cancer vaccines, or perhaps most importantly--how to apply statistical models to a new paradigm of data generation.

My schedule visible on the right (or who knows where in the mobile app--I know--I am working on it) is one day of a 5-day schedule of block presentations around specific topics in immunology.

How often are you reading late-breaking abstracts from a recent conference wishing you knew more about the methodological approach selected or consideration of patient selection? Immunology 2017 was easily one of the most data and science heavy conferences I have attended--the Q&A sessions and live abstract presentations were fascinating.

Seasoned scientists would applaud and ask for clarifications on statistical modeling, clinical endpoints, and broad or narrow applicability of research findings.

If you want to stay in the "know" sign up for the mailing list or follow along on social media. We have a lot of "incredible" to discover...
Picture

Comments are closed.
    Bonny is a data enthusiast applying curated analysis and visualization to persistent tensions between health policy, economics, and clinical research in oncology.
    Follow @datamongerbonny

    Archives

    November 2020
    January 2020
    October 2019
    August 2019
    July 2019
    January 2019
    December 2018
    August 2018
    June 2018
    April 2018
    March 2018
    December 2017
    November 2017
    September 2017
    June 2017
    May 2017
    April 2017
    October 2016
    September 2016
    August 2016
    April 2016
    March 2016
    November 2015
    October 2015
    September 2015
    July 2015
    June 2015
    May 2015
    April 2015

    Categories

    All

    Subscribe to our mailing list

    * indicates required
    Email Format
Proudly powered by Weebly
  • Data & Donuts (thinky thoughts)
  • COLLABORATor
  • Data talks, people mumble
  • Cancer: The Brand
  • Time to make the donuts...
  • donuts (quick nibbles)
  • Tools for writers and soon-to-be writers
  • datamonger.health
  • The "How" of Data Fluency